New Rhein Healthcare

New Rhein Healthcare, established in 2010 and headquartered in Philadelphia, is a venture capital firm specializing in healthcare therapeutics and medical devices. Its team comprises former industry executives with operational and transactional experience. The firm invests in companies that leverage proven products in new applications, such as new indications, dosage forms, or 505(b2) pathways. New Rhein assembles syndicates of operationally focused investors to support portfolio companies in various aspects, including development, regulatory affairs, reimbursement, marketing, and contract manufacturing. The firm also helps portfolio companies build their value proposition by understanding what strategic partners find attractive. New Rhein's investment focus spans healthcare devices, supplies, pharmaceuticals, and biotechnology sectors, with a global reach across Europe and the United States.